SMO ClinPlus CO.,LTD. (SHE:301257)
China
· Delayed Price · Currency is CNY 54.02
-3.12 (-5.46%)
At close: Apr 29, 2026
SMO ClinPlus CO.,LTD. Market Cap
SMO ClinPlus CO.,LTD. has a market cap or net worth of 4.51 billion as of April 29, 2026. Its market cap has increased by 79.98% in one year.
Market Cap
4.51B
Enterprise Value
3.90B
Revenue
842.50M
Ranking
n/a
PE Ratio
41.41
Stock Price
54.02
Market Cap Chart
Since May 17, 2022, SMO ClinPlus CO.,LTD.'s market cap has increased from 4.48B to 4.51B, an increase of 0.80%. That is a compound annual growth rate of 0.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 4.51B | 9.80% |
| Dec 31, 2025 | 4.11B | 91.80% |
| Dec 31, 2024 | 2.14B | -44.81% |
| Dec 29, 2023 | 3.88B | 32.91% |
| Dec 30, 2022 | 2.92B | -34.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Thalys Medical Technology Group | 4.48B |
| Guangdong Hybribio Biotech | 3.83B |
| Shanghai Labway Clinical Laboratory | 3.78B |
| Medicalsystem Biotechnology | 3.71B |
| Berry Genomics Co.,Ltd | 3.45B |
| Cowealth Medical China | 6.19B |
| Maccura Biotechnology Co.Ltd | 6.31B |
| Chemclin Diagnostics | 2.86B |